DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR GEMZAR

« Back to Dashboard

Clinical Trials for Gemzar

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00002998	Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer	Completed	National Cancer Institute (NCI)	Phase 2	1997-08-01	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of gemcitabine and cisplatin in treating patients with metastatic breast cancer that has not responded to systemic therapy.
NCT00002998	Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer	Completed	Alliance for Clinical Trials in Oncology	Phase 2	1997-08-01	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of gemcitabine and cisplatin in treating patients with metastatic breast cancer that has not responded to systemic therapy.
NCT00003182	Cisplatin and Gemcitabine in Treating Patients With Advanced Squamous Cell Cancer of the Head and Neck	Unknown status	Hope Cancer Institute, Inc.	Phase 1/Phase 2	1997-03-01	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of cisplatin and gemcitabine in treating patients with advanced squamous cell cancer of the head and neck that cannot be surgically removed.

Clinical Trial Conditions for Gemzar

Condition Name

Condition Name for Gemzar
Intervention	Trials
Pancreatic Cancer	26
Pancreatic Neoplasms	13
Breast Cancer	10

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Gemzar
Intervention	Trials
Pancreatic Neoplasms	64
Adenocarcinoma	25
Carcinoma, Non-Small-Cell Lung	23

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Gemzar

Trials by Country

Trials by Country for Gemzar
Location	Trials
United States	549
Italy	58
Germany	31
United Kingdom	26
Australia	23

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Gemzar
Location	Trials
Texas	37
Florida	27
New York	25
California	25
Minnesota	24

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Gemzar

Clinical Trial Phase

Clinical Trial Phase for Gemzar
Clinical Trial Phase	Trials
Phase 4	3
Phase 3	25
Phase 2/Phase 3	4

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Gemzar
Clinical Trial Phase	Trials
Completed	68
Recruiting	46
Not yet recruiting	27

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Gemzar

Sponsor Name

Sponsor Name for Gemzar
Sponsor	Trials
Eli Lilly and Company	24
National Cancer Institute (NCI)	23
Celgene Corporation	9

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Gemzar
Sponsor	Trials
Other	187
Industry	120
NIH	23

Export unavailable in trial.
Subscribe for complete access.